Page last updated: 2024-09-05

tetraphenylphosphonium chloride and Leukemia, Myeloid

tetraphenylphosphonium chloride has been researched along with Leukemia, Myeloid in 1 studies

*Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Karaliota, A; Litos, C; Scorilas, A; Thomadaki, H1

Other Studies

1 other study(ies) available for tetraphenylphosphonium chloride and Leukemia, Myeloid

ArticleYear
Enhanced antileukemic activity of the novel complex 2,5-dihydroxybenzoate molybdenum(VI) against 2,5-dihydroxybenzoate, polyoxometalate of Mo(VI), and tetraphenylphosphonium in the human HL-60 and K562 leukemic cell lines.
    Journal of medicinal chemistry, 2007, Mar-22, Volume: 50, Issue:6

    Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Gentisates; HL-60 Cells; Humans; K562 Cells; Leukemia, Myeloid; Magnetic Resonance Spectroscopy; Necrosis; Onium Compounds; Organometallic Compounds; Organophosphorus Compounds; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet

2007